PubRank

Magali Giral

Author PubWeight™ 43.30‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans. J Clin Invest 2010 3.41
2 Patients with drug-free long-term graft function display increased numbers of peripheral B cells with a memory and inhibitory phenotype. Kidney Int 2010 2.28
3 Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance. Proc Natl Acad Sci U S A 2007 2.27
4 Upregulation of miR-142-3p in peripheral blood mononuclear cells of operationally tolerant patients with a renal transplant. J Am Soc Nephrol 2012 1.81
5 Contrasting CD25hiCD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation 2006 1.75
6 Identification of a gene expression profile associated with operational tolerance among a selected group of stable kidney transplant patients. Transpl Int 2011 1.73
7 Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl Int 2007 1.65
8 Frequency and clinical implications of development of donor-specific and non-donor-specific HLA antibodies after kidney transplantation. J Am Soc Nephrol 2005 1.36
9 Regulatory, effector, and cytotoxic T cell profiles in long-term kidney transplant patients. J Am Soc Nephrol 2009 1.05
10 Contrasted blood and intragraft toll-like receptor 4 mRNA profiles in operational tolerance versus chronic rejection in kidney transplant recipients. Transplantation 2008 1.04
11 A clinical scoring system highly predictive of long-term kidney graft survival. Kidney Int 2010 1.03
12 Immunosuppressive drug-free operational immune tolerance in human kidney transplant recipients: Part I. Blood gene expression statistical analysis. J Cell Biochem 2008 1.03
13 Tribbles-1 as a novel biomarker of chronic antibody-mediated rejection. J Am Soc Nephrol 2008 1.03
14 Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation 2007 1.01
15 Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 2005 1.00
16 A semi-Markov model for multistate and interval-censored data with multiple terminal events. Application in renal transplantation. Stat Med 2007 1.00
17 Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection. PLoS One 2013 0.97
18 Phenotypically and functionally distinct CD8+ lymphocyte populations in long-term drug-free tolerance and chronic rejection in human kidney graft recipients. J Am Soc Nephrol 2005 0.95
19 Adherence with immunosuppressive treatment after transplantation: results from the French trial PREDICT. Clin Transplant 2012 0.93
20 Analysis of the peripheral T-cell repertoire in kidney transplant patients. Eur J Immunol 2010 0.89
21 The effect of a first kidney transplant on a subsequent transplant outcome: an experimental and clinical study. Kidney Int 2005 0.87
22 Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection. Kidney Int 2010 0.85
23 Elaboration of gene expression-based clinical decision aids for kidney transplantation: where do we stand? Transplantation 2011 0.83
24 Implication of matrix metalloproteinase 7 and the noncanonical wingless-type signaling pathway in a model of kidney allograft tolerance induced by the administration of anti-donor class II antibodies. J Immunol 2008 0.83
25 The involvement of SMILE/TMTC3 in endoplasmic reticulum stress response. PLoS One 2011 0.82
26 Immunosuppressive drug-free operational immune tolerance in human kidney transplants recipients. Part II. Non-statistical gene microarray analysis. J Cell Biochem 2008 0.82
27 Can immune monitoring help to minimize immunosuppression in kidney transplantation? Transpl Int 2008 0.81
28 Poor long-term outcome in second kidney transplantation: a delayed event. PLoS One 2012 0.81
29 Profiling posttransplant circulating antibodies in kidney transplantation using donor endothelial cells. Transplantation 2012 0.80
30 Rationale and criteria of eligibility for calcineurin inhibitor interruption following kidney transplantation. Curr Opin Organ Transplant 2008 0.80
31 Using biomarkers of tolerance and rejection to identify high- and low-risk patients following kidney transplantation. Transplantation 2009 0.78
32 Influence of graft characteristics on the outcome of kidney transplantation. N Engl J Med 2006 0.77
33 An alternative approach to estimate age-related mortality of kidney transplant recipients compared to the general population: results in favor of old-to-old transplantations. Transpl Int 2013 0.77
34 Net time-dependent ROC curves: a solution for evaluating the accuracy of a marker to predict disease-related mortality. Stat Med 2014 0.76
35 Bortezomib in the treatment of antibody-mediated rejection--a report of 3 cases. Clin Transpl 2009 0.76
36 Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation. Am J Transplant 2005 0.76
37 Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. J Clin Invest 2015 0.76
38 Operational tolerance in kidney transplantation-improved terminology may enable more precise investigation. Transplantation 2013 0.76
39 Differential modulation of donor-specific antibodies after B-cell depleting therapies to cure chronic antibody mediated rejection. Transplantation 2015 0.75
40 Comparison of the risk factors effects between two populations: two alternative approaches illustrated by the analysis of first and second kidney transplant recipients. BMC Med Res Methodol 2013 0.75
41 Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy. Exp Clin Transplant 2014 0.75
42 Influence of anemia on patient and graft survival after renal transplantation: results from the French DIVAT cohort. Transplantation 2014 0.75
43 Cut-off estimation and medical decision making based on a continuous prognostic factor: the prediction of kidney graft failure. Int J Biostat 2012 0.75
44 Chronic rejection of human kidney allografts. Expert Rev Clin Immunol 2006 0.75
45 Early and irreversible recurrence MPO-ANCA-positive glomerulonephritis after renal transplantation. Clin Nephrol 2015 0.75
46 How well do pre- and peritransplant variables predict the long-term results of kidney transplantation? Clin Transpl 2008 0.75
47 Six months anti-viral prophylaxis significantly decreased cytomegalovirus disease compared with no anti-viral prophylaxis following renal transplantation. Transpl Int 2010 0.75
48 Does pre-emptive kidney transplantation with a deceased donor improve outcomes? Results from a French transplant network. Transpl Int 2010 0.75